Expand JAZZ Menu
JAZZ MENU

JAZZ Stock Posts


Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -212.66+4.83 (+2.3%)

Jazz Pharmaceuticals PLC - trades 4,005 contracts. JAZZ will report earnings on Nov 2, 2026.
View Details...
Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -214.98+3.01 (+1.4%)

Jazz Pharmaceuticals PLC - trades 2,959 contracts. The highest volume is in the 18-Dec-26 240 calls, which is 11.6% above the current price.
View Details...
Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -264.67+10.20 (+4.0%)

Jazz Pharmaceuticals PLC - trades 2,793 contracts. The company has the following event: on Aug 25, 2026. News: U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
View Details...
Upcoming Earnings

JAZZ Jazz Pharmaceuticals PLC -251.62-1.24 (-0.5%)

Jazz Pharmaceuticals PLC - will report earnings after the market closes. View Calendar The market is expecting a ±7.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±7.4%. View Expected Move (Conf Call: Aug 3 4:30 PM)
$JAZZ Earnings May 05 AMC. Expected Move ±7.8% vs Prev. Move +13.2%
Upcoming Earnings

JAZZ Jazz Pharmaceuticals PLC -209.62+1.56 (+0.8%)

Jazz Pharmaceuticals PLC - will report earnings after the market closes. View Calendar The market is expecting a ±6.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±7.7%. View Expected Move (Conf Call: May 5 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes